Companies Home Search Profile

*NEW*General Considerations for Clinical Studies ICH E8 (R1)

Focused View

Dr. Vincent Baeyens

2:31:00

80 View
  • 1 - Welcome and Objectives of the Course.mp4
    03:11
  • 2 - Purpose of ICH E8.mp4
    11:13
  • 3 - Link between ICH E8 and ICH GCP E6.mp4
    04:15
  • 4 - ICH-GCP-R3-Overarching-Principles-Version-March-2021.pdf
  • 4 - Protection of Clinical Study Participants.mp4
    03:36
  • 5 - Scientific Approach in Clinical Study.mp4
    09:45
  • 6 - FDA-Guidance-1-Collecting-Comprehensive-and-Representative-Input.pdf
  • 6 - FDA-Guidance-2-Methods-to-Identify-What-is-Important-to-Patients.pdf
  • 6 - FDA-Guidance-3-DRAFT-Selecting-Developing-or-Modifying-Fit-for-Purpose-Clinical-Outcomes-Assessments.pdf
  • 6 - ICH-ReflectionPaper-PFDD-FinalRevisedPostConsultation-2021-0602.pdf
  • 6 - ICH-ReflectionPaper-PFDD-OutcomeOfPublicConsutlation-2021-0527.pdf
  • 6 - Patient Input into Drug Development.mp4
    12:15
  • 6 - ich-reflection-paper-proposed-ich-guideline-work-advance-patient-focused-drug-development-pfdd-en.pdf
  • 7 - Strategy for implementing Quality by Design into Clinical Studies.mp4
    04:02
  • 8 - Considerations-in-Identifying-Critical-to-Quality-Factors-in-Clinical-Research.pdf
  • 8 - Definition of Critical to Quality Factors.mp4
    08:26
  • 8 - Example-of-Factors-Principles-Document-CTTI.pdf
  • 9 - Approach to Identifying Critical to Quality Factors.mp4
    14:07
  • 10 - General Principles of Drug Development Planning.mp4
    02:55
  • 11 - Quality of Investigational Medicinal Product.mp4
    03:53
  • 12 - Scope and Timing of Nonclinical Studies with respect to Clinical Studies.mp4
    03:16
  • 13 - Optimizing Clinical Development Planning.mp4
    17:29
  • 14 - Additional Development.mp4
    01:58
  • 15 - Conclusions and Ways to Move Forward.mp4
    07:34
  • 16 - Background and Rationale.mp4
    02:03
  • 17 - Definition of Study Population.mp4
    05:22
  • 18 - Treatment Description.mp4
    01:44
  • 19 - Choice of Control Group.mp4
    05:34
  • 20 - Response Variables.mp4
    04:21
  • 21 - Methods to Reduce Bias.mp4
    04:54
  • 22 - Statistical Analysis.mp4
    04:17
  • 23 - Study Data.mp4
    05:21
  • 24 - Study Conduct.mp4
    04:26
  • 25 - Safety Monitoring during Study Conduct.mp4
    02:27
  • 26 - Study Reporting.mp4
    01:27
  • 27 - Case Studies and Assignment.html
  • 27 - Case-studies-QbD.pdf
  • 28 - Conclusion.mp4
    01:09
  • Description


    Key Concept for ICH GCP E6 (R3) - Guideline on Best Practices to Design Quality into Clinical Studies

    What You'll Learn?


    • Understand the General Quality Principles of Clinical Research
    • Understand why a revision to the original E8 was needed
    • Understand the link between ICH E8 and ICH-Good Clinical Practice (GCP) E6 (R3)
    • Learn how to identify Critical to Quality (CtQ) factors
    • Identify and understand the ICH E8 requirements for optimal design and conduct clinical studies
    • Learn and understand how to apply the process to implement good design quality into clinical studies
    • Learn how to utilize good study design practice to optimize drug development planning
    • Understand the key elements of the study protocol that may be used to optimize the design of a study
    • Learn from the experience in case studies where Quality-by-Design (QbD) was implemented Vs not implemented

    Who is this for?


  • This course is intended to all professionals involved in the design and conduct of clinical studies across the product lifecycle, such as clinical development & operations personnel.
  • What You Need to Know?


  • This course is dedicated to all professionals willing to learn how to design quality into their clinical studies
  • More details


    Description

    Welcome to this ICH E8(R1) course to design quality into your Clinical Studies !


    The ICH E8 (R1) is the umbrella guideline of the ICH family and works hand-in-hand with the ICH E6 Good Clinical Practice (R3) guideline.

    This guideline provides an overall introduction to clinical development, with a focus on designing quality into clinical trials and identifying critical factors that impact the quality of the trials in order to facilitate acceptance of data and results by regulatory authorities worldwide.

    The guideline emphasizes the importance of considering quality throughout the clinical trial lifecycle, from study design and planning to conduct, analysis, and reporting. It highlights the need to manage risks that may impact the safety of study participants and the reliability of trial data, and provides guidance on how to do so.

    In this course, you will learn to implement the quality by design (QbD) concept in the design, planning, conduct and reporting of your clinical trials. This course will help focus on what really matters in order to ensure the protection of study participants, the integrity of the data and reliability and the ability of the studies to meet their objectives. This course complements well the GCP rules that all clinical research professionals must follow.

    I designed this course for any clinical research professional seeking to learn how to better design quality in their clinical studies and anticipate problems that may occur.

    Together, I will walk you through the QbD concepts based on my experience, so that you will be able to apply QbD to your daily practice.

    We will :

    • Understand the General Quality Principles of Clinical Research

    • Understand the link between ICH E8 and ICH GCP E6

    • Learn how to identify Critical to Quality factors

    • Identify and understand the ICH E8 requirements for optimal design and conduct clinical studies

    • Understand and learn how to apply the process to implement good design quality into clinical studies

    • Learn how to utilize good study design practice to optimize drug development planning

    • Understand the key elements of the study protocol that may be used to optimize the design of a study

    • Learn from the experience in real case studies where QbD was implemented Vs not implemented

    This course is dedicated to all clinical research professionals willing to learn how to design quality into their clinical studies in line with the ICH GCP principles.

    To facilitate the learning experience, the course has been broken up on purpose in several small lectures. If you are a more advanced student, you can increase the speed of lecture to learn the course at your own pace.

    A final Practice Test at the end of the course will consolidate your knowledge.

    Feel free to look at the content of the course to know more and contact me any time if you have any questions!

    Are you ready?

    I am looking forward to seeing you inside this course!

    Sincerely,

    Vincent



    Who this course is for:

    • This course is intended to all professionals involved in the design and conduct of clinical studies across the product lifecycle, such as clinical development & operations personnel.

    User Reviews
    Rating
    0
    0
    0
    0
    0
    average 0
    Total votes0
    Focused display
    Dr. Vincent Baeyens
    Dr. Vincent Baeyens
    Instructor's Courses
    Vincent Baeyens, PhD is a recognized expert with over 25 years’ global R&D and clinical operations leadership experience in Clinical Research.He served as executive leader in several Global Pharma's and Biotech settings. He conducted Clinical Trials globally in Europe, US, India, Japan and Latin America.Vincent is also a trainer for CRO management and oversight, site selection and activation, risk assessment and enrolment tacticsVincent holds a master’s degree in Pharmacy, from the University of Louvain in Belgium, and a PhD in Pharmaceutical Science, from the University of Geneva, Switzerland.
    Students take courses primarily to improve job-related skills.Some courses generate credit toward technical certification. Udemy has made a special effort to attract corporate trainers seeking to create coursework for employees of their company.
    • language english
    • Training sessions 27
    • duration 2:31:00
    • Release Date 2023/06/11